NEU 0.81% $12.25 neuren pharmaceuticals limited

Ann: Phase 2 trial shows significant improvements in Pitt Hopkins, page-62

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 13 Posts.
    lightbulb Created with Sketch. 20
    I'm just so relieved and elated about these results for the Phase II for Pitt-Hopkins. Further establishes how effective this drug can be in this certain spectrum of conditions. I must admit that the reaction of the market is slightly underwhelming, and this can be because of many reasons voiced out before by many. Thankfully, I've also learned to temper my expectations from being with the company after all these years.

    Is it just me who muted the zoom meeting while Liza is speaking? I was cringing a bit and can't look at the screen, hence just muted it. LOL. Sounded like someone who had to present something for the first time. Now before I get crucified for being someone who just sees these trivial flaws, lighten up, it was just my observation. I know pretty petty like the spelling checks going on. Otherwise, absolutely happy today (as well as what's been happening with DXB as well). Congratulations to all holders and patients (and their families)!
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$12.25
Change
-0.100(0.81%)
Mkt cap ! $1.565B
Open High Low Value Volume
$12.20 $12.25 $12.02 $3.677M 302.0K

Buyers (Bids)

No. Vol. Price($)
1 1579 $12.21
 

Sellers (Offers)

Price($) Vol. No.
$12.26 1199 1
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.